Abiopharma

News list

Newton Charles W. 🔴 sold 551 shares of Keros Therapeutics, Inc. (KROS) at $10.30 Transaction Date: Aug 18, 2026 | Filing ID: 000010

Full text

News bot Aug. 20, 2026, 8:10 p.m.
🔍 Newton Charles W. (Executive)

Company: Keros Therapeutics, Inc. (KROS)

Report Date: 2026-08-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 551
Detailed Transactions and Holdings:
- Sold 551 shares of Common Stock at $10.3 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,114.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.